• Molecular NameQuinacrine
  • SynonymAcrichine; Acrinamine; Acriquine; Akrichin; Antimalarina; Atabrine; Atebrin; Atebrine; Erion; Erion Hydrochloride; Haffkinine; Italchine; Mepacrine; Quinactine
  • Weight399.966
  • Drugbank_IDDB01103
  • ACS_NO83-89-6
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)6.13
  • pka7.73; 10.2
  • LogD (pH=7, predicted)1.53
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-2.41
  • LogSw (predicted, AB/LogsW2.0)0.0
  • Sw (mg/ml) (predicted, ACD/Labs)0.03
  • No.of HBond Donors1
  • No.of HBond Acceptors4
  • No.of Rotatable Bonds9
  • TPSA37.39
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA drug with a number of different medical applications. It is related to Mefloquine.
  • Absorption_valueN/A
  • Absorption (description)Absorbed rapidly from the gastrointestinal tract following oral administration.
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding99.0
  • Volume of distribution (VD)124 L/kg
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life5~14 days
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicitySymptoms of overdose include seizures, hypotension, cardiac arrhythmias, and cardiovascular collapse.
  • LD50 (rat)LD50=900 mg/kg
  • LD50 (mouse)LD50=1000 mg/kg